je.st
news
IPO-bound Aduro snags Big Pharma cancer immunotherapy deal
2015-03-30 11:22:11| Biotech - Topix.net
Tiny Aduro Biotech Inc. hopes to put the STING on cancer with a potential $750 million deal between the Berkeley company and drug giant Novartis AG. The deal centers on experimental synthetic small molecules, developed by Aduro, that could be the latest weapon in the hot field of cancer immunotherapy.
Tags: big
deal
cancer
pharma
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||